Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2011 Dec 8;21(7):697–709. doi: 10.1002/pds.2256

Table 2.

a. Empirical results for the NSAID study. Key within-PS interactions were included in PS models.

Model Entire Cohort
(n=49,711)
Males
(n=7,854)
Females
(n=41,857)
Age <75
(n=14,103)
Age ≥75
(n=35,608)
High Risk
(n=12,627)a
Exposed outcomes N 503 71 432 83 420 348
Unexposed outcomes N 243 57 186 49 194 157
Unadjusted OR [CI] 1.14 [0.98, 1.33] 0.92 [0.65, 1.30] 1.21 [1.02, 1.44] 1.30 [0.91, 1.86] 1.04 [0.87, 1.23] 0.91 [0.75, 1.10]
Age/sex adjusted OR [CI] 1.08 [0.92, 1.26] 0.87 [0.61, 1.24] 1.14 [0.95, 1.35] 1.32 [0.93, 1.89] 1.02 [0.86, 1.21] 0.88 [0.73, 1.07]
Adjusted by all covariates OR [CI] 0.87 [0.71, 1.08] 0.68 [0.42, 1.12] 0.93 [0.73, 1.17] 1.07 [0.67, 1.72] 0.83 [0.65, 1.05] 0.74 [0.53, 1.04]
PS estimated within subgroup (PSSS) "Referent Standard"
Adj. by deciles of PSSS OR [CI] 0.93 [0.79, 1.09] 0.80 [0.55, 1.15] 0.96 [0.80, 1.15] 1.04 [0.72, 1.50] 0.91 [0.76, 1.09] 0.90 [0.74, 1.10]
Distanceb 0.026 0.116 0.030 0.062 0.036 0.082
Matched on PSSS N Matched 33,188 5,812 27,368 10,758 22,370 7,204
OR [CI] 0.97 [0.81, 1.17] 0.83 [0.55, 1.27] 0.95 [0.77, 1.16] 0.98 [0.64, 1.48] 0.89 [0.73, 1.10] 0.91 [0.72, 1.14]
Distance 0.001 0.003 0.001 0.002 0.001 0.003
PS estimated overall (PSCOH) and applied within subgroup
Adj. by deciles of PSCOH OR [CI] 0.93 [0.79, 1.09] 0.79 [0.55, 1.13] 0.96 [0.81, 1.15] 1.01 [0.70, 1.46] 0.92 [0.77, 1.10] 0.90 [0.74, 1.09]
Difference (%) c 0.00 (0.0%) −0.01 (−1.4%) 0.00 (0.0%) −0.03 (−2.7%) 0.01 (1.3%) −0.01 (−0.7%)
Distance 0.026 0.127 0.032 0.069 0.036 0.089
Matched on PSCOH N Matched 33,188 5,826 27,368 10,810 22,398 7,232
OR [CI] 0.97 [0.81, 1.17] 0.74 [0.49, 1.13] 1.03 [0.84, 1.26] 0.98 [0.64, 1.49] 0.96 [0.79, 1.18] 0.79 [0.62, 1.01]
Difference (%) 0.00 (0.0%) −0.09 (−11.0%) 0.08 (8.8%) −0.00 (−0.1%) 0.07 (7.7%) −0.11 (−12.5%)
Distance 0.001 0.006 0.001 0.006 0.001 0.015
Matched pairs from PSCOH matches
Matched on PSCOH N Matched 33,188 1,278 22,886 5,000 16,482 2,112
OR [CI] 0.97 [0.81, 1.17] 1.00 [0.45, 2.24] 0.99 [0.79, 1.23] 0.52 [0.26, 1.05] 1.05 [0.83, 1.33] 0.87 [0.54, 1.39]
Difference (%) 0.00 (0.0%) 0.17 (19.9%) 0.04 (4.4%) −0.46 (−46.9%) 0.16 (17.7%) −0.04 (−4.2%)
Distance 0.001 0.024 0.001 0.014 0.002 0.036
b. Empirical results for the Pennsylvania APM study. Key within-PS interactions were included in PS models.

Model Entire Cohort
(n=46,659)
Males
(n=7,841)
Females
(n=38,818)
Age <75
(n=10,035)
Age ≥75
(n=36,624)
High Risk
(n=29,994)a
Exposed outcomes N 6214 1546 4668 1213 5001 4454
Unexposed outcomes N 2061 510 1551 127 1934 1667
Unadjusted OR [CI] 1.36 [1.29, 1.44] 1.44 [1.28, 1.61] 1.35 [1.27, 1.43] 2.26 [1.87, 2.74] 1.37 [1.29, 1.45] 1.37 [1.29, 1.46]
Age/sex adjusted OR [CI] 1.58 [1.50, 1.67] 1.62 [1.44, 1.83] 1.57 [1.47, 1.67] 2.36 [1.95, 2.86] 1.51 [1.43, 1.61] 1.56 [1.46, 1.66]
Adjusted by all covariates OR [CI] 1.25 [1.16, 1.33] 1.21 [1.05, 1.40] 1.25 [1.16, 1.35] 1.29 [1.02, 1.63] 1.26 [1.17, 1.36] 1.27 [1.18, 1.38]
PS estimated within subgroup (PSSS) "Referent Standard"
Adj. by deciles of PSSS OR [CI] 1.24 [1.16, 1.33] 1.19 [1.03, 1.37] 1.27 [1.17, 1.37] 1.19 [0.94, 1.49] 1.26 [1.17, 1.35] 1.27 [1.18, 1.38]
Distanceb 0.365 0.828 0.359 2.037 0.296 0.420
Matched on PSSS N Matched 18,548 3,166 15,372 2,668 15,766 12,660
OR [CI] 1.27 [1.17, 1.37] 1.18 [1.00, 1.39] 1.28 [1.17, 1.40] 1.11 [0.84, 1.47] 1.26 [1.16, 1.36] 1.26 [1.15, 1.38]
Distance 0.004 0.017 0.005 0.024 0.004 0.005
PS estimated overall (PSCOH) and applied within subgroup
Adj. by deciles of PSCOH OR [CI] 1.24 [1.16, 1.33] 1.18 [1.03, 1.36] 1.27 [1.17, 1.37] 1.44 [1.15, 1.81] 1.24 [1.16, 1.33] 1.26 [1.16, 1.36]
Difference (%)c 0.00 (0.0%) −0.01 (−0.9%) 0.00 (0.0%) 0.25 (21.3%) −0.02 (−1.4%) −0.02 (−1.3%)
Distance 0.365 1.091 0.365 1.973 0.306 0.397
Matched on PSCOH N Matched 18,548 3,164 15,402 2,700 15,848 12,674
OR [CI] 1.27 [1.17, 1.37] 1.10 [0.93, 1.30] 1.26 [1.15, 1.38] 1.27 [0.97, 1.67] 1.24 [1.14, 1.34] 1.22 [1.12, 1.34]
Difference (%) 0.00 (0.0%) −0.08 (−6.5%) −0.02 (−1.2%) 0.16 (14.7%) −0.02 (−1.6%) −0.03 (−2.7%)
Distance 0.004 0.041 0.006 0.093 0.011 0.014
Matched pairs from PSCOH matches
Matched on PSCOH N Matched 18,548 578 12,868 462 13,454 8,402
OR [CI] 1.27 [1.17, 1.37] 1.27 [0.86, 1.89] 1.28 [1.16, 1.41] 1.28 [0.69, 2.38] 1.23 [1.13, 1.35] 1.31 [1.18, 1.47]
Difference (%) 0.00 (0.0%) 0.10 (8.1%) 0.01 (0.5%) 0.17 (15.5%) −0.03 (−2.1%) 0.06 (4.5%)
Distance 0.004 0.151 0.007 0.257 0.015 0.019
c. Empirical results for the British Columbia APM study. Key within-PS interactions were included in PS models.

Model Entire Cohort
(n=42,565)
Males
(n=16,790)
Females
(n=25,775)
Age <75
(n=11,899)
Age ≥75
(n=30,666)
High Risk
(n=6,519)a
Exposed outcomes N 3883 2052 1831 1190 2693 619
Unexposed outcomes N 3015 1445 1570 430 2585 568
Unadjusted OR [CI] 2.41 [2.29, 2.54] 2.31 [2.14, 2.50] 2.37 [2.21, 2.55] 4.37 [3.88, 4.91] 2.09 [1.97, 2.22] 1.79 [1.58, 2.03]
Age/sex adjusted OR [CI] 2.44 [2.32, 2.58] 2.41 [2.23, 2.60] 2.47 [2.29, 2.66] 4.44 [3.95, 5.00] 2.06 [1.94, 2.19] 1.84 [1.62, 2.09]
Adjusted by all covariates OR [CI] 2.10 [1.97, 2.23] 1.96 [1.79, 2.16] 2.22 [2.04, 2.43] 2.83 [2.44, 3.27] 1.90 [1.77, 2.04] 1.60 [1.38, 1.86]
PS estimated within subgroup (PSSS) "Referent Standard"
Adj. by deciles of PSSS OR [CI] 1.92 [1.81, 2.04] 1.80 [1.65, 1.97] 2.04 [1.88, 2.22] 2.51 [2.20, 2.86] 1.79 [1.67, 1.92] 1.53 [1.33, 1.77]
Distanceb 0.112 0.148 0.142 0.246 0.104 0.287
Matched on PSSS N Matched 22,358 9,074 13,234 6,558 15,612 3,670
OR [CI] 1.89 [1.76, 2.03] 1.74 [1.58, 1.92] 2.15 [1.95, 2.38] 2.48 [2.13, 2.89] 1.72 [1.59, 1.87] 1.45 [1.23, 1.71]
Distance 0.003 0.004 0.004 0.005 0.002 0.009
PS estimated overall (PSCOH) and applied within subgroup
Adj. by deciles of PSCOH OR [CI] 1.92 [1.81, 2.04] 1.82 [1.67, 1.99] 2.03 [1.87, 2.21] 2.70 [2.37, 3.07] 1.76 [1.64, 1.89] 1.40 [1.21, 1.61]
Difference (%)c 0.00 (0.0%) 0.02 (1.1%) −0.01 (−0.5%) 0.19 (7.7%) −0.03 (−1.7%) −0.13 (−8.7%)
Distance 0.112 0.151 0.136 0.304 0.127 0.382
Matched on PSCOH N Matched 22,358 9,090 13,266 6,640 15,664 3,708
OR [CI] 1.89 [1.76, 2.03] 1.76 [1.60, 1.95] 2.09 [1.89, 2.31] 2.55 [2.20, 2.96] 1.71 [1.58, 1.86] 1.25 [1.06, 1.47]
Difference (%) 0.00 (0.0%) 0.02 (1.3%) −0.06 (−2.8%) 0.08 (3.1%) −0.01 (−0.5%) −0.20 (−14.0%)
Distance 0.003 0.013 0.005 0.061 0.015 0.078
Matched pairs from PSCOH matches
Matched on PSCOH N Matched 22,358 4,140 8,182 2,492 11,382 620
OR [CI] 1.89 [1.77, 2.03] 1.75 [1.51, 2.03] 2.08 [1.83, 2.36] 2.51 [1.95, 3.23] 1.68 [1.52, 1.84] 1.10 [0.75, 1.60]
Difference (%) 0.01 (0.3%) 0.01 (0.6%) −0.08 (−3.5%) 0.04 (1.5%) −0.05 (−2.6%) −0.35 (−24.3%)
Distance 0.003 0.032 0.009 0.090 0.020 0.163
a

Patients with prior gastrointestinal-related diagnoses or hospitalizations.

b

Mahalanobis distance between patients in the exposure and referent categories. In the decile analyses, the distance is measured within each decile and then averaged.

c

Difference between the observed odds ratio after adjusting by or matching on PSCOH versus PSSS.

a

Patients with a history of cerebrovascular disease, myocardial infarction, or arrhythmias.

b

Mahalanobis distance between patients in the exposure and referent categories. In the decile analyses, the distance is measured within each decile and then averaged.

c

Difference between the observed odds ratio after adjusting by or matching on PSCOH versus PSSS.

a

Patients with a history of cerebrovascular disease, myocardial infarction, or arrhythmias.

b

Mahalanobis distance between patients in the exposure and referent categories. In the decile analyses, the distance is measured within each decile and then averaged.

c

Difference between the observed odds ratio after adjusting by or matching on PSCOH versus PSSS.